Nanosphere

New Validation and Clinical Outcome Data From Several Studies on Nanosphere's Gram-Positive and Gram-Negative Blood Culture Tests to Be Presented at ASM 2013

Nanosphere to Present at UBS Global Healthcare Conference

Nanosphere rises 15.8%

ACT, THRX Hit All-time High, NSPH Makes A Big Move, BTX Gets Funding

After-market Movers For May 13 (TTWO, PDII, NSPH, SCTY, MOSY, SPH)

Nanosphere announces agreement with Hitachi High-Technologies

Nanosphere Announces Distribution and Collaboration Agreement With Hitachi High-Technologies Corporation

Jefferies Stocks to Buy: Big Gains in Life Sciences and Diagnostics

Nanosphere backs FY13 revenue guidance of $13M-$15M, consensus $12.97M

Nanosphere sells 1.923M shares of common stock at $2.60